nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—TUBB4B—Docetaxel—melanoma	0.295	0.498	CbGbCtD
Mebendazole—ABCB1—melanoma	0.262	1	CbGaD
Mebendazole—CYP1A1—Dacarbazine—melanoma	0.12	0.203	CbGbCtD
Mebendazole—CYP3A4—Temozolomide—melanoma	0.067	0.113	CbGbCtD
Mebendazole—ABCB1—Dactinomycin—melanoma	0.0407	0.0686	CbGbCtD
Mebendazole—CYP3A4—Vemurafenib—melanoma	0.0367	0.0618	CbGbCtD
Mebendazole—ABCB1—Docetaxel—melanoma	0.021	0.0354	CbGbCtD
Mebendazole—TUBA1A—optic choroid—melanoma	0.0129	0.224	CbGeAlD
Mebendazole—CYP3A4—Docetaxel—melanoma	0.0126	0.0212	CbGbCtD
Mebendazole—TUBA1A—hair follicle—melanoma	0.00522	0.0905	CbGeAlD
Mebendazole—TUBB4B—skin epidermis—melanoma	0.00487	0.0845	CbGeAlD
Mebendazole—TUBA1A—neck—melanoma	0.0035	0.0607	CbGeAlD
Mebendazole—TUBB4B—hair follicle—melanoma	0.00348	0.0603	CbGeAlD
Mebendazole—CYP1A1—skin epidermis—melanoma	0.00273	0.0473	CbGeAlD
Mebendazole—TUBA1A—eye—melanoma	0.0026	0.0452	CbGeAlD
Mebendazole—TUBA1A—retina—melanoma	0.00258	0.0447	CbGeAlD
Mebendazole—Ketoprofen—CXCR1—melanoma	0.00228	0.433	CrCbGaD
Mebendazole—TUBA1A—skin of body—melanoma	0.00227	0.0393	CbGeAlD
Mebendazole—TUBA1A—mammalian vulva—melanoma	0.00207	0.0358	CbGeAlD
Mebendazole—TUBB4B—eye—melanoma	0.00174	0.0301	CbGeAlD
Mebendazole—TUBB4B—retina—melanoma	0.00172	0.0298	CbGeAlD
Mebendazole—TUBB4B—skin of body—melanoma	0.00151	0.0262	CbGeAlD
Mebendazole—TUBA1A—head—melanoma	0.00148	0.0256	CbGeAlD
Mebendazole—TUBB4B—mammalian vulva—melanoma	0.00138	0.0239	CbGeAlD
Mebendazole—TUBA1A—lymph node—melanoma	0.00104	0.0179	CbGeAlD
Mebendazole—TUBB4B—head—melanoma	0.000985	0.0171	CbGeAlD
Mebendazole—ABCB1—blood vessel—melanoma	0.000948	0.0164	CbGeAlD
Mebendazole—CYP1A1—skin of body—melanoma	0.000845	0.0147	CbGeAlD
Mebendazole—CYP1A1—mammalian vulva—melanoma	0.000771	0.0134	CbGeAlD
Mebendazole—Albendazole—ABCB1—melanoma	0.000705	0.134	CrCbGaD
Mebendazole—TUBB4B—lymph node—melanoma	0.00069	0.012	CbGeAlD
Mebendazole—Ketoprofen—CXCL8—melanoma	0.000576	0.109	CrCbGaD
Mebendazole—CYP1A1—head—melanoma	0.000552	0.00957	CbGeAlD
Mebendazole—Ketorolac—PTGS2—melanoma	0.000535	0.102	CrCbGaD
Mebendazole—ABCB1—retina—melanoma	0.0005	0.00867	CbGeAlD
Mebendazole—Tiaprofenic acid—PTGS2—melanoma	0.000436	0.0827	CrCbGaD
Mebendazole—Nepafenac—PTGS2—melanoma	0.000415	0.0787	CrCbGaD
Mebendazole—ABCB1—mammalian vulva—melanoma	0.0004	0.00694	CbGeAlD
Mebendazole—CYP1A1—lymph node—melanoma	0.000386	0.0067	CbGeAlD
Mebendazole—ABCB1—head—melanoma	0.000287	0.00497	CbGeAlD
Mebendazole—ABCB1—lymph node—melanoma	0.000201	0.00348	CbGeAlD
Mebendazole—Ketoprofen—PTGS2—melanoma	0.000168	0.0319	CrCbGaD
Mebendazole—Ketoprofen—ALB—melanoma	0.00015	0.0284	CrCbGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	7.21e-05	0.000885	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—melanoma	7.14e-05	0.000877	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—melanoma	7.14e-05	0.000877	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—melanoma	7.14e-05	0.000877	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	7.06e-05	0.000867	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—E2F1—melanoma	7.05e-05	0.000865	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—PRKCA—melanoma	6.9e-05	0.000847	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—CD80—melanoma	6.89e-05	0.000846	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN2B—melanoma	6.86e-05	0.000843	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—melanoma	6.8e-05	0.000835	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—melanoma	6.8e-05	0.000835	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—melanoma	6.75e-05	0.000828	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—PCNA—melanoma	6.64e-05	0.000816	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN2A—melanoma	6.5e-05	0.000798	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDKN1B—melanoma	6.44e-05	0.00079	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—CASP8—melanoma	6.4e-05	0.000786	CbGpPWpGaD
Mebendazole—CYP1A1—PPARA activates gene expression—PPARG—melanoma	6.38e-05	0.000783	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—MDM2—melanoma	6.3e-05	0.000774	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—E2F1—melanoma	6.3e-05	0.000773	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—melanoma	6.24e-05	0.000766	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—PRKCA—melanoma	6.17e-05	0.000758	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—ABCB1—melanoma	6.15e-05	0.000755	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CCND1—melanoma	6.14e-05	0.000754	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	6.13e-05	0.000753	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—IGF1—melanoma	6.11e-05	0.00075	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDK2—melanoma	6.08e-05	0.000746	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDKN1A—melanoma	5.94e-05	0.000729	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—PCNA—melanoma	5.94e-05	0.000729	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—MMP2—melanoma	5.91e-05	0.000726	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	5.9e-05	0.000725	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CUBN—melanoma	5.89e-05	0.000723	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN1B—melanoma	5.76e-05	0.000707	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDK4—melanoma	5.74e-05	0.000705	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TERT—melanoma	5.74e-05	0.000704	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—melanoma	5.73e-05	0.000704	CbGpPWpGaD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	5.54e-05	0.000681	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—GPAM—melanoma	5.51e-05	0.000676	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CCND1—melanoma	5.49e-05	0.000674	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—IFNG—melanoma	5.45e-05	0.000669	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDK2—melanoma	5.43e-05	0.000667	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	5.36e-05	0.000658	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN1A—melanoma	5.31e-05	0.000652	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ACER3—melanoma	5.19e-05	0.000637	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—ATM—melanoma	5.16e-05	0.000633	CbGpPWpGaD
Mebendazole—CYP3A4—Tryptophan metabolism—MDM2—melanoma	5.14e-05	0.000631	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDK4—melanoma	5.14e-05	0.00063	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—MAPK3—melanoma	5.07e-05	0.000622	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—CXCL8—melanoma	5.06e-05	0.000622	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—RB1—melanoma	4.99e-05	0.000613	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—MYC—melanoma	4.93e-05	0.000605	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—CXCL8—melanoma	4.91e-05	0.000603	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—CASP3—melanoma	4.85e-05	0.000595	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—IL2—melanoma	4.84e-05	0.000594	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—MAPK1—melanoma	4.82e-05	0.000592	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	4.82e-05	0.000591	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	4.75e-05	0.000583	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—UGT2B10—melanoma	4.75e-05	0.000583	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	4.69e-05	0.000575	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—MMP1—melanoma	4.61e-05	0.000566	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP17A1—melanoma	4.55e-05	0.000559	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—CTNNB1—melanoma	4.53e-05	0.000557	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—MAPK3—melanoma	4.53e-05	0.000556	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	4.52e-05	0.000555	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	4.49e-05	0.000551	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—RB1—melanoma	4.47e-05	0.000548	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	4.42e-05	0.000543	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HS3ST5—melanoma	4.41e-05	0.000542	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—MYC—melanoma	4.4e-05	0.000541	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2A—melanoma	4.39e-05	0.000539	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	4.38e-05	0.000537	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	4.33e-05	0.000532	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—MAPK1—melanoma	4.31e-05	0.000529	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—melanoma	4.3e-05	0.000528	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	4.25e-05	0.000522	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	4.17e-05	0.000512	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ACER3—melanoma	4.14e-05	0.000509	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—VEGFA—melanoma	4.11e-05	0.000505	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	4.1e-05	0.000503	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	4.02e-05	0.000493	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN2A—melanoma	3.92e-05	0.000482	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN1B—melanoma	3.89e-05	0.000477	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—ALB—melanoma	3.85e-05	0.000472	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP1B1—melanoma	3.83e-05	0.00047	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	3.81e-05	0.000468	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—MDM2—melanoma	3.81e-05	0.000467	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—UGT2B10—melanoma	3.79e-05	0.000465	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	3.78e-05	0.000464	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CCND1—melanoma	3.71e-05	0.000455	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—IGF1—melanoma	3.69e-05	0.000453	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	3.62e-05	0.000444	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TP53—melanoma	3.62e-05	0.000444	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	3.61e-05	0.000443	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN1A—melanoma	3.59e-05	0.00044	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—MMP2—melanoma	3.57e-05	0.000438	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	3.55e-05	0.000436	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—TNF—melanoma	3.52e-05	0.000433	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HS3ST5—melanoma	3.52e-05	0.000433	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN1B—melanoma	3.48e-05	0.000427	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	3.39e-05	0.000417	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	3.35e-05	0.000412	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PLCB4—melanoma	3.34e-05	0.00041	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CCND1—melanoma	3.32e-05	0.000407	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—FASN—melanoma	3.28e-05	0.000403	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN1A—melanoma	3.21e-05	0.000394	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	3.16e-05	0.000388	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SLC6A11—melanoma	3.14e-05	0.000386	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIP4K2A—melanoma	3.14e-05	0.000386	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	3.11e-05	0.000381	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—MAPK3—melanoma	3.06e-05	0.000375	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—MTAP—melanoma	3.06e-05	0.000375	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	3.03e-05	0.000372	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	3e-05	0.000369	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.99e-05	0.000367	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—MYC—melanoma	2.97e-05	0.000365	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—CXCL8—melanoma	2.97e-05	0.000364	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—MAPK1—melanoma	2.91e-05	0.000357	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	2.86e-05	0.000351	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—CTNNB1—melanoma	2.74e-05	0.000336	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—MAPK3—melanoma	2.73e-05	0.000336	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PHGDH—melanoma	2.73e-05	0.000335	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—LUM—melanoma	2.73e-05	0.000335	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	2.71e-05	0.000333	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HPSE—melanoma	2.67e-05	0.000328	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	2.67e-05	0.000328	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PLCB4—melanoma	2.67e-05	0.000328	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—MYC—melanoma	2.66e-05	0.000327	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	2.63e-05	0.000323	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CUBN—melanoma	2.62e-05	0.000322	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—MAPK1—melanoma	2.6e-05	0.000319	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	2.58e-05	0.000316	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ACER3—melanoma	2.55e-05	0.000313	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SDHD—melanoma	2.53e-05	0.000311	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—BSG—melanoma	2.53e-05	0.000311	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CSPG4—melanoma	2.53e-05	0.000311	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SLC6A11—melanoma	2.51e-05	0.000308	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIP4K2A—melanoma	2.51e-05	0.000308	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GPAM—melanoma	2.45e-05	0.000301	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.45e-05	0.000301	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—MTAP—melanoma	2.44e-05	0.0003	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	2.44e-05	0.0003	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	2.39e-05	0.000294	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—UGT2B10—melanoma	2.34e-05	0.000287	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	2.33e-05	0.000286	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	2.31e-05	0.000283	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	2.25e-05	0.000276	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	2.25e-05	0.000276	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	2.24e-05	0.000275	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TP53—melanoma	2.18e-05	0.000268	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PHGDH—melanoma	2.18e-05	0.000267	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—LUM—melanoma	2.18e-05	0.000267	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HS3ST5—melanoma	2.17e-05	0.000267	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HPSE—melanoma	2.13e-05	0.000262	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CUBN—melanoma	2.1e-05	0.000257	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PLA2G6—melanoma	2.09e-05	0.000256	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	2.03e-05	0.000249	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SDHD—melanoma	2.02e-05	0.000248	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CSPG4—melanoma	2.02e-05	0.000248	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—BSG—melanoma	2.02e-05	0.000248	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GPAM—melanoma	1.96e-05	0.000241	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.92e-05	0.000236	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—VCAN—melanoma	1.87e-05	0.00023	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.87e-05	0.000229	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.83e-05	0.000224	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.83e-05	0.000224	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.77e-05	0.000218	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.74e-05	0.000214	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.73e-05	0.000212	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.71e-05	0.00021	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PLA2G6—melanoma	1.67e-05	0.000205	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PLCB4—melanoma	1.65e-05	0.000202	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.59e-05	0.000195	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP17A1—melanoma	1.58e-05	0.000194	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.56e-05	0.000191	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLC6A11—melanoma	1.55e-05	0.00019	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIP4K2A—melanoma	1.55e-05	0.00019	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—melanoma	1.54e-05	0.000189	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.53e-05	0.000188	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MTAP—melanoma	1.5e-05	0.000185	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—VCAN—melanoma	1.5e-05	0.000184	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GNA11—melanoma	1.49e-05	0.000183	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—FASN—melanoma	1.46e-05	0.000179	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SLC5A5—melanoma	1.44e-05	0.000176	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GNAQ—melanoma	1.39e-05	0.00017	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CD44—melanoma	1.39e-05	0.00017	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.36e-05	0.000167	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.35e-05	0.000165	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PHGDH—melanoma	1.34e-05	0.000165	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—LUM—melanoma	1.34e-05	0.000165	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP1B1—melanoma	1.33e-05	0.000163	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HPSE—melanoma	1.32e-05	0.000161	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.29e-05	0.000159	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CUBN—melanoma	1.29e-05	0.000158	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP17A1—melanoma	1.26e-05	0.000155	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SDHD—melanoma	1.25e-05	0.000153	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—BSG—melanoma	1.25e-05	0.000153	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CSPG4—melanoma	1.25e-05	0.000153	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GPAM—melanoma	1.21e-05	0.000148	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GNA11—melanoma	1.19e-05	0.000146	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.17e-05	0.000144	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.17e-05	0.000144	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—FASN—melanoma	1.17e-05	0.000143	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SLC5A5—melanoma	1.15e-05	0.000141	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GNAQ—melanoma	1.11e-05	0.000136	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CD44—melanoma	1.11e-05	0.000136	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ABCB1—melanoma	1.1e-05	0.000135	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP1B1—melanoma	1.06e-05	0.000131	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PLA2G6—melanoma	1.03e-05	0.000126	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PRKCA—melanoma	1.01e-05	0.000124	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ERCC2—melanoma	1e-05	0.000123	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—VCAN—melanoma	9.22e-06	0.000113	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.29e-06	0.000102	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PRKCA—melanoma	8.06e-06	9.89e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ERCC2—melanoma	7.99e-06	9.81e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CG—melanoma	7.9e-06	9.7e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP17A1—melanoma	7.78e-06	9.55e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PPARG—melanoma	7.63e-06	9.36e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GNA11—melanoma	7.35e-06	9.02e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—FASN—melanoma	7.19e-06	8.83e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLC5A5—melanoma	7.07e-06	8.68e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CD—melanoma	6.95e-06	8.53e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ALB—melanoma	6.86e-06	8.42e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GNAQ—melanoma	6.83e-06	8.39e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CD44—melanoma	6.83e-06	8.39e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP1B1—melanoma	6.55e-06	8.04e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CG—melanoma	6.31e-06	7.75e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PPARG—melanoma	6.09e-06	7.48e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CB—melanoma	6.05e-06	7.43e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PTGS2—melanoma	6e-06	7.36e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CD—melanoma	5.55e-06	6.81e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ALB—melanoma	5.48e-06	6.72e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ABCB1—melanoma	5.39e-06	6.62e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PTEN—melanoma	5.23e-06	6.42e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PRKCA—melanoma	4.96e-06	6.09e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ERCC2—melanoma	4.92e-06	6.04e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CB—melanoma	4.84e-06	5.94e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PTGS2—melanoma	4.79e-06	5.88e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PTEN—melanoma	4.18e-06	5.13e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CG—melanoma	3.89e-06	4.77e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PPARG—melanoma	3.75e-06	4.61e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CA—melanoma	3.69e-06	4.53e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CD—melanoma	3.42e-06	4.2e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ALB—melanoma	3.37e-06	4.14e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—AKT1—melanoma	3.02e-06	3.7e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CB—melanoma	2.98e-06	3.66e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PTGS2—melanoma	2.95e-06	3.62e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CA—melanoma	2.95e-06	3.62e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PTEN—melanoma	2.57e-06	3.16e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—AKT1—melanoma	2.41e-06	2.96e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CA—melanoma	1.82e-06	2.23e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AKT1—melanoma	1.48e-06	1.82e-05	CbGpPWpGaD
